Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Amortization of Deferred Charges (2023 - 2025)

Camp4 Therapeutics' Amortization of Deferred Charges history spans 3 years, with the latest figure at -$1000.0 for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges fell 106.67% year-over-year to -$1000.0; the TTM value through Dec 2025 reached $16000.0, down 80.72%, while the annual FY2025 figure was $16000.0, 80.72% down from the prior year.
  • Amortization of Deferred Charges for Q4 2025 was -$1000.0 at Camp4 Therapeutics, down from $1000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $111000.0 in Q1 2025 and bottomed at -$95000.0 in Q2 2025.
  • The 3-year median for Amortization of Deferred Charges is $19000.0 (2024), against an average of $14333.3.
  • The largest YoY upside for Amortization of Deferred Charges was 311.11% in 2025 against a maximum downside of 531.82% in 2025.
  • A 3-year view of Amortization of Deferred Charges shows it stood at $30000.0 in 2023, then crashed by 50.0% to $15000.0 in 2024, then crashed by 106.67% to -$1000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Amortization of Deferred Charges are -$1000.0 (Q4 2025), $1000.0 (Q3 2025), and -$95000.0 (Q2 2025).